Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity
1 other identifier
interventional
1,250
1 country
1
Brief Summary
Tonsillectomy, with or without adenoidectomy, in both children and adults is worldwide one of the most commonly performed surgical procedures in otorhinolaryngology, and the number is increasing. Alone in Denmark, approximately 8.000 tonsillectomies are performed annually. Although, tonsillectomy on benign indication is considered to be a minor and frequently performed surgical procedure, the operation is associated with significant morbidity. Postoperative pain and post tonsillectomy haemorrhage (PTH) are the most frequent, and PTH is potentially life threatening. In cold steel tonsillectomy, the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery. This method has been used for the past 50 years, and is considered the "Gold Standard". However, new so-called "hot techniques have been developed. One of these is an impedance-dependent tissue sealer device (BiZactTM). The equipment used for BiZactTM tonsillectomy is EC certificated (CE nr. 00500). The equipment is commonly used for tonsillectomy both internationally and in Denmark, and preliminary results in both adults and children are promising. However, when a gold standard technique is replaced by a new technique, it is recommended that the decision is based on evidence obtained in randomized controlled designs, and preferably as a multicenter study. Within the scope of the CE marking of the equipment, the purpose of the present study is to conduct a randomized controlled trial (RCT) in order to investigate whether tonsillectomy performed with BiZactTM "hot" technique is beneficial or at least non-inferior compared to the gold standard cold steel technique in terms of affecting the incidence of post-tonsillectomy morbidity, interoperative factors, patient satisfaction, and health related quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2022
CompletedFirst Posted
Study publicly available on registry
March 8, 2022
CompletedStudy Start
First participant enrolled
May 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2025
CompletedFebruary 17, 2025
February 1, 2025
2.2 years
February 15, 2022
February 13, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Incidence of PTH
• Incidence of PTH defined as haemorrhage requiring haemostasis with; bipolar electric coagulation, ligature, compression and/or medical treatment with antifibrinolyticum within the first 24 hours after surgery until 30 days after surgery.
24 hours until 30 days after surgery
Postoperative pain
• Postoperative pain assessed on a 11point numeric rating scale ranging from 0 "no pain" to 10 "worst possible pain". The Wong-Baker Faces rating scale is used for children.
From the day of surgery until 14 days after the surgery
Secondary Outcomes (6)
Blood loss
Intraoperative
Knife time
First day of surgery
PROM
From the day of the surgery until 6 months after the surgery
Unscheduled contacts to the health care system
From the day of the surgery until 14 days after
Health related quality of life
From the day of the surgery until 6 months after the surgery
- +1 more secondary outcomes
Study Arms (2)
BiZact
EXPERIMENTALCold Steel
ACTIVE COMPARATORInterventions
In the "hot group" the peritonsillar space is dissected and sealed in one step by a bipolar instrument (BiZactTM). The instrument uses Valley Lab adjustable bipolar energy. Energy is automatically adjusted and delivered to the tissue in order minimize thermal tissue damage and seal blood vessels less than 3mm in diameter while dividing the soft tissue.
In the "cold steel group" the peritonsillar space is dissected with metal instruments, and bleeding is typically controlled by ligation or electrocautery.
Eligibility Criteria
You may qualify if:
- Obstruction/ tonsillar hypertrophy.
- Recurrent tonsillitis, including previous peritonsillar abscess
- Chronic tonsillitis
- Systemic complications to tonsillitis (glomerulonephritis)
- Other (Mononucleosis), PFAPA (Periodic Fever, Aphtous stomatitis, pharyngitis, cervical adenitis)
- Foetor ex ore (tonsillar plugs)
- Peritonsillar abscess (Tonsillectomy a chaud)
- Ability to understand the written patient information and to give informed consent
You may not qualify if:
- Diseases in the hematopoietic system
- Antithrombotic or anticoagulant drugs in the recovery period
- Suspicion of/known tonsillar malignancies or other malignancy
- Patients or caregivers unable to read or speak Danish
- Patients or caregivers unable to use online application for self-evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Line Schiøtt Nissenlead
- Sygehus Lillebaeltcollaborator
- Sonderborg Hospitalcollaborator
- Esbjerg Hospital - University Hospital of Southern Denmarkcollaborator
- Aalborg University Hospitalcollaborator
Study Sites (1)
Line Schiøtt Nissen
Gødstrup, 7400, Denmark
Related Publications (2)
Molhave M, Lyhne NM, Jensen DF, Nielsen SH, Hahn P, Holm JK, Ovesen T, Bertelsen J. BiZact versus cold steel for post-tonsillectomy hemorrhage: a multicenter randomized trial. Eur Arch Otorhinolaryngol. 2025 Dec;282(12):6449-6457. doi: 10.1007/s00405-025-09703-3. Epub 2025 Oct 13.
PMID: 41083818DERIVEDNissen LS, Bertelsen J, Lyhne NM, Nielsen SH, Hahn P, Holm J, Ovesen T. Cold steel versus impedance-dependent tissue sealer tonsillectomy - a study protocol for a randomised controlled trial. Dan Med J. 2023 Nov 23;70(12):A06230366.
PMID: 38018707DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Line S Nissen, MD
Regional Hospital West Jutland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
February 15, 2022
First Posted
March 8, 2022
Study Start
May 1, 2022
Primary Completion
July 25, 2024
Study Completion
January 21, 2025
Last Updated
February 17, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share